GBNH
10/15/26

Greenbrook TMS (GBNH)

Thursday
2:59 AM
ThesisThe company is facing significant operational challenges and competitive pressures that may hinder revenue growth.

Revenue Outlook

★ Analysts see FY2024 revenue reaching $100M — +25.7% growth in a single year.

What Moves the Stock

  1. 01Changes in reimbursement policies for TMS therapy
  2. 02Expansion of clinic locations in high-demand areas
  3. 03Patient volume growth driven by increased awareness of mental health treatments
  4. 04Regulatory changes affecting mental health treatment protocols
  5. 05TMS therapy sessions - 80%
  6. 06Consultation services - 15%
  7. 07Other mental health services - 5%
  8. 08Growing acceptance of mental health treatment in mainstream healthcare
FY2022 Snapshot
EPS
$-3.73

GBNH Chart

No chart data

My Notes

  • "Management noted, 'We are navigating a challenging landscape with increasing competition and regulatory pressures.'"
  • Moat: The company's established network and proprietary treatment protocols provide a moderate level of competitive advantage.
  • growth - Investors interested in expanding mental health markets and innovative treatment solutions.
  • Minimal impact as the company primarily relies on cash flows from operations rather than debt financing.
  • Watch on earnings: Number of TMS therapy sessions conducted, Patient acquisition costs, Revenue growth rate.

One Sentence Summary:

Greenbrook TMS: the story is balanced — changes in reimbursement policies for tms therapy.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.